The type 2 diabetes market in Mexico will grow to $1.22 billion in 2014, forecasts research and advisory firm Decision Resources. Drivers of this growth include increasing prevalent population, expanding medical insurance coverage as well as the launch and use of new drugs in the market.
"Mexico now has the largest type 2 diabetes population in the world behind the USA, China, Japan and India," said Decision Resources analyst Yannick Maneuf. "As the population ages, the size of Mexico's prevalent type 2 diabetes population will continue to grow. We also expect the diagnosed rate of type 2 diabetes will continue to increase as the Mexican government actively promotes early diagnosis of diabetes," he noted.
Fixed-dose combo drugs will garner over $332 million
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze